Advertisement

Topics

Takeda And TiGenix Announce That Swissmedic Has Accepted For Review The File On Cx601 For The Treatment Of Complex Perianal Fistulas In Crohn's Disease Patients

20:00 EDT 19 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Takeda And TiGenix Announce That Swissmedic Has Accepted For Review The File On Cx601 For The Treatment Of Complex Perianal Fistulas In Crohn's Disease Patients

NEXT ARTICLE

More From BioPortfolio on "Takeda And TiGenix Announce That Swissmedic Has Accepted For Review The File On Cx601 For The Treatment Of Complex Perianal Fistulas In Crohn's Disease Patients"

Advertisement
Quick Search
Advertisement
Advertisement